Imovax d.T. Dosage/Direction for Use

Posology: For adults, adolescents and children from 6 years of age, the dose is 0.5 mL.
Booster vaccination of previously immunized individuals: Booster vaccination against tetanus and diphtheria should be based on official recommendations regarding the type of tetanus-diphtheria containing vaccine to be used and interval since previous vaccination.
Booster vaccination with Imovax d.T. consists of one dose (0.5 mL) of Imovax d.T. (see Pharmacology: Pharmacodynamics under Actions).
In adults previously vaccinated and with important delay since last tetanus-diphtheria vaccination (range 11 to 60 years) a second booster dose (0.5 mL) may be required at least one month after the first booster dose for some individuals (see Pharmacology: Pharmacodynamics under Actions). The decision to administer a second booster dose should be based on the assessment of antibodies level (serological test) achieved after the first booster dose.
Post-exposure prophylaxis of tetanus: In subjects previously immunized against tetanus, Imovax d.T. could be used for post-exposure prophylaxis of tetanus if in accordance with official recommendations.
Other pediatric population: The safety and efficacy of Imovax d.T. in children less than 6 years of age have not been established.
Method of administration: Imovax d.T. should be given by intramuscular injection. The preferred injection site is the deltoid muscle.
Imovax d.T. must not be administered by intradermal or intravascular routes.
For instructions on handling, see Special precautions for disposal and other handling under Cautions for Usage.